Alzamend Neuro, Inc. Quarterly Net Cash Provided by (Used in) Operating Activities in USD from Q2 2020 to Q2 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
Summary
Alzamend Neuro, Inc. quarterly/annual Net Cash Provided by (Used in) Operating Activities history and growth rate from Q2 2020 to Q2 2025.
  • Alzamend Neuro, Inc. Net Cash Provided by (Used in) Operating Activities for the quarter ending July 31, 2025 was -$2.36M, a 124% decline year-over-year.
  • Alzamend Neuro, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2024 was -$6.57M, a 20.6% increase from 2023.
  • Alzamend Neuro, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2023 was -$8.27M, a 7.32% increase from 2022.
  • Alzamend Neuro, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2022 was -$8.92M, a 34.9% decline from 2021.
Net Cash Provided by (Used in) Operating Activities, Quarterly (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2025 -$2.36M -$1.31M -124% May 1, 2025 Jul 31, 2025 10-Q 2025-09-10
Q2 2024 -$1.06M +$2.24M +68% May 1, 2024 Jul 31, 2024 10-Q 2025-09-10
Q2 2023 -$3.3M -$762K -30% May 1, 2023 Jul 31, 2023 10-Q 2024-09-11
Q2 2022 -$2.54M -$1.31M -107% May 1, 2022 Jul 31, 2022 10-Q 2023-09-13
Q2 2021 -$1.22M -$1.02M -496% May 1, 2021 Jul 31, 2021 10-Q 2022-09-13
Q2 2020 -$205K May 1, 2020 Jul 31, 2020 10-Q 2021-09-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.